CareRx Corporation's latest earnings report reveals a significant shortfall in EPS, raising questions about its financial trajectory.
In its recent earnings report for the second quarter of 2026, CareRx Corp (CRRX.TO) reported an earnings per share (EPS) of $0.01, falling short of analyst expectations of $0.03, marking a surprise of -66.67%. This disappointing performance comes after a mixed earnings history, contributing to a cautious outlook among investors.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$230.31M
P/E
8.6x
Div. yield
2.25%
Div. / share
$0.08
52W high
$3.95
52W low
$2.77
1W change
+2.34%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 46.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+46.9% Upside
Current Price
C$3.50
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
25.4%
Annualized
90-Day Vol
26.7%
Annualized
Trend (90d)
-6.0%
Annualized drift
90d Mean
C$3.43
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.48 | C$3.18 – C$3.79 |
| 60 trading days | C$3.45 | C$3.05 – C$3.91 |
| 90 trading days | C$3.43 | C$2.94 – C$3.99 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-02 | — | 0.0300 | — |
| 2026-06-30 | 2026-07-29 | 0.0100 | 0.0300 | -66.7% |
| 2026-03-31 | 2026-05-06 | 0.0200 | 0.0700 | -71.4% |
| 2025-12-31 | 2026-03-04 | 0.3700 | 0.0300 | +1133.3% |
| 2025-09-30 | 2025-11-03 | 0.0200 | 0.0300 | -33.3% |
| 2025-06-30 | 2025-07-30 | 0.0100 | 0.0100 | +0.0% |
Advertisement
Investor takeaway: Investors should carefully assess CareRx's recent earnings miss as it highlights potential challenges in achieving growth targets. With a current P/E ratio of 8.64 and a market cap of approximately CAD 230 million, the stock remains under scrutiny as it navigates a competitive healthcare landscape.
Earnings Miss by 66.67% with EPS at $0.01 vs $0.03 Estimated
The latest earnings report reflects ongoing challenges for CareRx, as it struggles to meet EPS estimates, which have been revised downwards in the last 30 days from $0.04 to $0.03.
Bull case
Despite the earnings miss, analysts remain optimistic about CareRx, giving it a bullish consensus rating. The average price target is CAD 5.14, suggesting a potential upside of nearly 47% from its last close of CAD 3.50. The company's dividend yield of 2.25% also provides some income stability amid market fluctuations.
Bear case
On the flip side, the significant earnings miss raises concerns about the company's operational efficiency and its ability to meet growth expectations. With only one earnings beat in the last four quarters, there may be growing skepticism from investors and analysts.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
